Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.
Emamzadeh FN, Surguchov A. · 2018
Read Parkinson's Disease: Biomarkers, Treatment, and Risk Factors. by Emamzadeh FN, Surguchov A. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6125353.txt.
Description
Emamzadeh and Surguchov wrote a review in Frontiers in Neuroscience on Parkinson's disease. Parkinson's stems mainly from a lack of dopamine in the brain. Dopamine aids movement, drive, and memory. The disease often goes unseen early, since cell damage starts long before symptoms.
The review covers markers that could catch the disease sooner. They span clinic signs, brain scans, body fluids, and genes. Forms of the protein alpha-synuclein draw much focus. Tiny RNA markers and chemical profiling may add more. Standard drugs that replace dopamine are reviewed too. Risk factors range from toxins and pesticides to head injury and gene defects.
Catalog record
| CREATOR | Emamzadeh FN, Surguchov A. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 81 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |